1. Cost‐effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial. (7th June 2021) Authors: Okeke Ogwulu, CB; Williams, EV; Chu, JJ; Devall, AJ; Beeson, LE; Hardy, P; Cheed, V; Yongzhong, S; Jones, LL; La Fontaine Papadopoulos, JH; Bender‐Atik, R; Brewin, J; Hinshaw, K; Choudhary, M; Ahmed, A; Naftalin, J; Nunes, N; Oliver, A; Izzat, F; Bhatia, K Journal: BJOG Issue: Volume 128:Number 9(2021) Page Start: 1534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The cost‐effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial. (30th January 2020) Authors: Okeke Ogwulu, CB; Goranitis, I; Devall, AJ; Cheed, V; Gallos, ID; Middleton, LJ; Harb, HM; Williams, HM; Eapen, A; Daniels, JP; Ahmed, A; Bender‐Atik, R; Bhatia, K; Bottomley, C; Brewin, J; Choudhary, M; Deb, S; Duncan, WC; Ewer, AK; Hinshaw, K Journal: BJOG Issue: Volume 127:Number 6(2020) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗